Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Autism Spectrum Disorder Diagnostics Market Size, Value And Growth Trends Through 2030

The market for autism spectrum disorder diagnostics has experienced robust expansion lately, projected to increase from $28.87 billion in 2025 to $30.37 billion in 2026, reflecting a compound annual growth rate of 5.2%. This preceding growth phase has been fueled by heightened public awareness of ASD, the broadening scope of early childhood developmental screening initiatives, a rise in the number of qualified professionals capable of performing diagnoses, the increasing adoption of behavioral assessment methodologies, and enhanced accessibility to diagnostic services.

The market for autism spectrum disorder diagnostics is poised for consistent expansion over the coming years, projecting to reach a value of $36.76 billion by 2030, driven by a compound annual growth rate of 4.9%. This anticipated growth throughout the forecast period is underpinned by several key factors, including a surge in the demand for early intervention services, the increasing deployment of artificial intelligence-powered diagnostic instruments, the broadening reach of tele-diagnostics platforms, augmented investments in neurodevelopmental research, and advancements in the standardization of diagnostic criteria. Reflecting the prevailing trends within this domain, the forecast period is characterized by a greater embrace of digital screening tools, heightened utilization of recognized behavioral assessment scales, an expansion of diagnostic programs aimed at very young children, a more integrated approach to multidisciplinary diagnostics, and a stronger emphasis on achieving early and precise detection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16593&type=smp

Autism Spectrum Disorder Diagnostics Market Expansion Supported By Key Demand Factors

The expansion of dedicated diagnostic facilities is poised to be a significant driver for the autism spectrum disorders diagnostic market’s advancement. These centers, equipped with a multidisciplinary team of healthcare providers, psychologists, and experts, are instrumental in performing thorough evaluations and assessments essential for identifying autism spectrum disorder. Factors contributing to the increase in these specialized centers include leaps in diagnostic techniques, a growing need for integrated care approaches, enhanced professional development, ongoing research initiatives, and the increasing acknowledgment of autism as a crucial public health concern. By offering specialized knowledge, sophisticated diagnostic instruments, in-depth assessments, customized intervention strategies, support systems for families, and avenues for collaborative research, these centers significantly contribute to refining diagnostic precision, enabling prompt interventions, and ultimately improving the prognosis for individuals affected by ASD. Illustratively, in the United Kingdom, NHS England reported in July 2025 that its national Community Diagnostic Centre (CDC) Programme had greenlit 170 CDC locations throughout England. By August 2024, 165 of these sites were actively functioning across diverse environments, with 135 established within their permanent CDC structures and the remaining operating from temporary setups while their permanent facilities are finalized. Consequently, the proliferation of these specialized diagnostic centers is directly fueling the growth trajectory of the autism spectrum disorders diagnostic market.

Autism Spectrum Disorder Diagnostics Market Segments: Where Are The Largest Growth Opportunities?

The autism spectrum disorder diagnostics market covered in this report is segmented –

1) By Diagnostic Method: Behavioral And Developmental Screening Tools, Standardized Diagnostic Assessments, Genetic And Molecular Testing, Digital And AI-Based Diagnostic Tools

2) By Test Type: Observational And Questionnaire-Based Tests, Cognitive And Neurodevelopmental Assessments, Biomarker And Genetic Tests, Eye-Tracking And Sensor-Based Tests

3) By Age Group: Infants And Toddlers (0–3 years), Children (4–12 years), Adolescents And Adults

4) By End User: Hospitals And Specialty Clinics, Diagnostic And Reference Laboratories, Academic And Research Institutes

Subsegments:

1) By Behavioral And Developmental Screening Tools: Parent-Reported Screening Questionnaires, Clinician-Administered Developmental Checklists

2) By Standardized Diagnostic Assessments: Structured Behavioral Observation Assessments, Standardized Diagnostic Interviews

3) By Genetic And Molecular Testing: Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS) Panels

4) By Digital And AI-Based Diagnostic Tools: AI-Driven Behavioral Analysis Platforms, Digital Biomarker & Eye-Tracking Systems

Autism Spectrum Disorder Diagnostics Market Growth Trends Influencing Competitive Dynamics

Leading entities within the autism spectrum disorder diagnostics sector are engineering sophisticated technologies, including apparatuses employing Dynamic Quantification of Social-Visual Engagement (DQSVE), to enhance their market standing and offer superior diagnostic capabilities; this system meticulously records and scrutinizes a child’s visual engagement patterns at an impressive frequency of 120 observations each second, and as a notable illustration, the Marcus Autism Center, a US-based non-profit health and research institution, introduced the EarliPoint™ Evaluation in September 2023, a groundbreaking device that has received FDA authorization for the early detection of ASD in toddlers between 16 and 30 months of age, employing advanced eye-tracking to evaluate social interactions and drastically condensing the diagnostic process from multiple hours down to a mere 12 minutes.

Autism Spectrum Disorder Diagnostics Market Major Participants And Competitive Dynamics

Major companies operating in the autism spectrum disorder diagnostics market are Quest Diagnostics, Laboratory Corporation of America LabCorp, ARUP Laboratories, Invitae, Natera, Fulgent Genetics, Myriad Genetics, Sema4, PreventionGenetics, Color Genomics, Cognoa, EarliTec Diagnostics, Eurofins Scientific, Sonic Healthcare, Cerba HealthCare, Baylor Genetics, Mayo Clinic Laboratories, Bionano Genomics, Genomind, Blueprint Genetics

Access The Complete Autism Spectrum Disorder Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorder-diagnostics-global-market-report

Autism Spectrum Disorder Diagnostics Market Global Footprint: Which Region Holds Market Leadership?

Asia-Pacificwas the largest region in the autism spectrum disorder diagnostics market in 2025. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model